Rapid communication: insights into the role of extracellular vesicles during Auger radioimmunotherapy

Jihad Karam (1, 2) , Julie Constanzo (1, 2) , Alexandre Pichard (1, 2) , Laurent Gros (1, 2) , Joël Chopineau (3, 4) , Marie Morille (3, 4) , Jean-Pierre Pouget (1, 2)

1 IRCM - U1194 Inserm - UM - Institut de Recherche en Cancérologie de Montpellier
2 ICM - Institut régional de Cancérologie de Montpellier
3 ICGM - Institut Charles Gerhardt Montpellier - Institut de Chimie Moléculaire et des Matériaux de Montpellier
4 ENSCM - Ecole Nationale Supérieure de Chimie de Montpellier

Purpose: Non-targeted effects, including bystander and systemic effects, play a crucial role during Auger targeted radionuclide therapy. Here, we investigated whether small extracellular vesicles (sEVs) produced by irradiated cells could contribute to the bystander cytotoxic effects in vitro and also to therapeutic efficacy in vivo, after their injection in tumor xenografts. Materials and methods: B16F10 melanoma donor cells were exposed to radiolabeled antibodies (Auger radioimmunotherapy, RIT) for 48 h or to X-rays (donor cells). Then, donor cells were incubated with fresh medium for 2 h to prepare conditioned medium (CM) that was transferred onto recipient cells for bystander effect assessment, or used for sEVs enrichment. Resulting sEVs were incubated in vitro with recipient cells for determining bystander cytotoxicity, or injected in B16F10 melanoma tumors harbored by athymic and C57BL/6 mice. Results: In vitro analysis of bystander cytotoxic effects showed that CM killed about 30-40% of melanoma cells. SEVs isolated from CM contributed to this effect. Moreover, the double-stranded DNA (dsDNA) content was increased in sEVs isolated from CM of exposed cells compared to control (not exposed), but the difference was significant only for the X-ray condition. These results were supported by immunodetection of cytosolic dsDNA in donor cells, a phenomenon that should precede dsDNA enrichment in sEVs. However, sEVs cytotoxicity could not be detected in vivo. Indeed, in athymic and in immunocompetent mice that received four intratumoral injections of sEVs (1/day), tumor growth was not delayed compared with untreated controls. Tumor growth was slightly (not significantly) delayed in immunocompetent mice treated with sEVs from X-ray-exposed cells, and significantly with sEVs purified from CM collected after 48 h of incubation. These results highlight the need to determine the optimal conditions, including radiation absorbed dose and sEVs collection time, to obtain the strongest cytotoxic effects. Conclusions: This study demonstrates that sEVs could play a role during Auger RIT through bystander effects in vitro. No systemic effects were observed in vivo, under our experimental conditions. However, X-rays experiments showed that sEVs collection time might be influencing the nature of sEVs, a parameter that should also be investigated during Auger RIT.

Mots clés: Targeted radionuclide therapy; radiotherapy; Auger electrons; exosomes; extracellular vesicles

Domaines: Sciences du Vivant [q-bio]

Jihad Karam, Julie Constanzo, Alexandre Pichard, Laurent Gros, Joël Chopineau, et al.. Rapid communication: insights into the role of extracellular vesicles during Auger radioimmunotherapy. International Journal of Radiation Biology, 2021, pp.1 - 10. ⟨10.1080/09553002.2021.1955999⟩. ⟨hal-03367192⟩